Latest filing published 18 Jun 2026 for Recursion Pharmaceuticals, INC., €11k.
Insider track record
Bumpus Namandje: trading record in brief
Bumpus Namandje is a declared insider of Recursion Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 3 June 2026 and 18 June 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 18 June 2026 with a transaction (€11k) in Recursion Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bumpus Namandje
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,963 shares@ US$3.180.0007% mcap29.1% of flowClass ASEC144:0001959173-26-004759
- 4,386 shares@ US$3.540.0008% mcap35.4% of flowClass ASEC144:0001959173-26-004290
2 of 2 declarations
